Physician profile
Scott Gelman
NPI 1922426261
$8,593.49
in general payments reported to CMS, 2019-2025
8 companies · $92.20 in 2025
The $92.20 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,756 · 2020: $2,163 · 2021: $1,230 · 2022: $155 · 2023: $795 · 2024: $2,403 · 2025: $92.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,580 · Travel and Lodging: $1,304 · Food and Beverage: $406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,580.00 |
| Travel and Lodging | $1,303.90 |
| Food and Beverage | $405.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $4,756.08 | 2019-2023 | |
| Depuy Synthes Products, INC. | $1,580.00 | 2024 | |
| Stryker Corporation | $884.38 | 2022-2025 | Mako |
| Arthrex, INC. | $853.08 | 2020-2023 | |
| Medical Device Business Services, INC. | $290.48 | 2019-2024 | Velys |
| Depuy Synthes Sales INC. | $151.61 | 2019-2022 | |
| Smith+Nephew, INC. | $60.87 | 2023-2024 | Journey II, Evos |
| Silk Road Medical, INC. | $16.99 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Gelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.